Mukka Proteins IPO subscribed nearly 137 times on last day. Check GMP and other details
Mukka Proteins IPO GMP: Most analysts have given a subscribe recommendation for Mukka Proteins IPO from a long-term view over fair valuations and a unique business model. The company's shares are trading with a premium of Rs 25 in the unlisted market

Mukka Proteins IPO review
Most analysts gave a subscribe recommendation for the IPO from a long-term perspective over fair valuations and a unique business model.
"At the upper price band, the company is valued at P/E of 17.7x with a market cap of Rs 840 crore post issue of equity shares. We believe that valuations of the company are fairly priced and recommend a Subscribe-Long Term rating to the IPO," said Anand Rathi.
Mukka Proteins IPO GMP
In the unlisted market, the company's shares are trading with a premium of Rs 25, marginally lower from the last week.
Mukka Proteins IPO price band
The price band for the offer has been determined at Rs 26–28 per equity share. The IPO will fetch Rs 224 crore at the upper end of the price band. Investors can bid for a minimum of 535 equity shares and in multiples thereafter.
Also Read: Bharat Highways Invit IPO allotment: Check status, GMP, listing date and other details
Other details
The issue is being made through the book-building process, wherein 50% will be available for qualified institutional buyers, 15% for non-institutional investors, and 35% for retail investors.
Net proceeds raised through the issue will be used towards working capital requirements, investment in its associate, Ento Proteins, and funding working capital requirements as well as general corporate purposes.
The company sells its products domestically and exports them to over 10 countries, including Bahrain, Bangladesh, Chile, Indonesia, Malaysia, Myanmar, Philippines, China, Saudi Arabia, South Korea, Oman, Taiwan and Vietnam.
In FY23, the company's revenue from operations rose 53% year-on-year (YoY) to Rs 1,177 crore and net profit jumped over 80% to Rs 44 crore. For the six months ended September 2023 period, revenue stood at Rs 612 crore and profit was at Rs 32.3 crore.
Fedex Securities is the sole book-running lead manager and Cameo Corporate Services is the registrar of the offer.
(Disclaimer: Recommendations, suggestions, views, and opinions given by the experts are their own. These do not represent the views of The Economic Times)
Download ET Markets APP